Affiliation: University of Wuerzburg
- Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastasesChristian Schem
Department of Gynecology, University Hospital Schleswig Holstein, Campus Kiel, Germany
BMC Cancer 13:32. 2013..In this preclinical study we examined whether sunitinib, a multi-tyrosine kinase inhibitor which has anti-angiogenic and anti-resorptive activity, is effective in the prevention of bone metastases...